Recombinant Human Anti-malaria antigen x Human Anti-TLR1 Bispecific Antibody (scFv-CH3) (BSFC-H345)

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv-CH3) contains two chains. The anti-malaria antigen scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-TLR1 scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

malaria antigen & TLR1

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Target 2

TLR1

Gene ID

7096

UniProt ID

Q15399

Alternative Names

CD281; TIL; TIL. LPRS5; rsc786; TLR1; Toll-like receptor 1; TLR

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "malaria antigen & TLR1"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-malaria antigen x Human Anti-TLR1 Bispecific Antibody (scFv-CH3) (BSFC-H345). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-malaria antigen x Human Anti-TLR1 Bispecific Antibody (scFv-CH3) (CAT#: BSFC-H345)

Specifications

Targets

Customer Reviews and Q&As